학술논문

Glucose availability limits microglial nitric oxide production
Document Type
article
Source
Journal of Neurochemistry. 159(6)
Subject
Biological Sciences
Industrial Biotechnology
Neurosciences
Animals
Animals
Newborn
Cell Survival
Cells
Cultured
Female
Glucose
Lipopolysaccharides
Male
Mice
Mice
Inbred C57BL
Microglia
Nitric Oxide
Nitric Oxide Synthase Type II
abscess
hyperglycemia
iNOS
NADPH
pentose phosphate pathway
Biochemistry and Cell Biology
Neurology & Neurosurgery
Biochemistry and cell biology
Language
Abstract
Metabolic intermediates influence inflammation not only through signaling effects, but also by fueling the production of pro-inflammatory molecules. Microglial production of nitric oxide (NO) requires the consumption of NADPH. NADPH consumed in this process is regenerated from NADP+ primarily through the hexose monophosphate shunt, which can utilize only glucose as a substrate. These factors predict that glucose availability can be rate-limiting for glial NO production. To test this prediction, cultured astrocytes and microglia were incubated with lipopolysaccharide and interferon-γ to promote expression of inducible nitric oxide synthase, and the rate of NO production was assessed at defined glucose concentrations. Increased NO production was detected only in cultures containing microglia. The NO production was markedly slowed at glucose concentrations below 0.5 mM, and comparably reduced by inhibition of the hexose monophosphate shunt with 6-aminonicotinamide. Reduced NO production caused by glucose deprivation was partly reversed by malate, which fuels NADPH production by malate dehydrogenase, and by NADPH itself. These findings highlight the role of the hexose monophosphate shunt in fueling NO synthesis and suggest that microglial NO production in the brain may be limited at sites of low glucose availability, such as abscesses or other compartmentalized infections.